Researchers in the UK have used whole genome sequencing (WGS) to identify novel pathogenic variants in patients with inherited optic neuropathies (IONs).
Researchers in the UK have used whole genome sequencing (WGS) to identify novel pathogenic variants in patients with inherited optic neuropathies (IONs).